FTO and obesity disorder: Treatment with orlistat, SMF, SAF, or SMF + SAF for 3 weeks after induction of obesity significantly (****p < 0.0001) downregulated the mRNA levels of the FTO gene in all treatment groups in a dose-dependent manner when compared with the untreated group (Figure 2b).